Galmed Pharmaceuticals
GLMD
$0.39
Share price
-1.87%
Change (1 day)
26.61%
Change (1 year)
Categories
EPS for Galmed Pharmaceuticals (GLMD)
EPS in 2023 (TTM): -$6.69
According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$6.69. In 2022 the company made an earnings per share (EPS) of -$10.57 an increase over its 2021 EPS that were of -$19.80.
EPS history for Galmed Pharmaceuticals from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$6.69 | -36.71% |
| 2022 | -$10.57 | -46.62% |
| 2021 | -$19.80 | -2.22% |
| 2020 | -$20.25 | 39.18% |
| 2019 | -$14.55 | 70.18% |
| 2018 | -$8.55 | -41.84% |
| 2017 | -$14.70 | -34.23% |
| 2016 | -$22.35 | 56.84% |
| 2015 | -$14.25 | 9.2% |
| 2014 | -$13.05 | -53.43% |
| 2013 | -$28.02 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | -$2.36 | -64.72% | 🇺🇸 USA |
 Endo International
ENDPQ | -$4.02 | -39.91% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -$0.75 | -88.79% | 🇺🇸 USA |
 Catalent CTLT | -$1.29 | -80.72% | 🇺🇸 USA |